litlas
ログインアカウント作成

Ann D. Thor

1984–2022 年に発表

80
論文数
18,354
被引用数
75
h 指数
80
i10 指数

被引用数

Ann D. Thor の年別被引用数1984 年: 被引用 1 件1985 年: 被引用 9 件1986 年: 被引用 28 件1987 年: 被引用 46 件1988 年: 被引用 40 件1989 年: 被引用 21 件1990 年: 被引用 32 件1991 年: 被引用 28 件1992 年: 被引用 42 件1993 年: 被引用 51 件1994 年: 被引用 86 件1995 年: 被引用 103 件1996 年: 被引用 73 件1997 年: 被引用 119 件1998 年: 被引用 123 件1999 年: 被引用 109 件2000 年: 被引用 189 件2001 年: 被引用 183 件2002 年: 被引用 160 件2003 年: 被引用 187 件2004 年: 被引用 168 件2005 年: 被引用 188 件2006 年: 被引用 166 件2007 年: 被引用 126 件2008 年: 被引用 151 件2009 年: 被引用 176 件2010 年: 被引用 170 件2011 年: 被引用 163 件2012 年: 被引用 163 件2013 年: 被引用 128 件2014 年: 被引用 119 件2015 年: 被引用 106 件2016 年: 被引用 90 件2017 年: 被引用 85 件2018 年: 被引用 78 件2019 年: 被引用 232 件2020 年: 被引用 256 件2021 年: 被引用 194 件2022 年: 被引用 132 件2023 年: 被引用 95 件2024 年: 被引用 127 件2025 年: 被引用 62 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,086 件、この内訳の 35.9%イギリス: 引用元論文 399 件、この内訳の 6.9%中国: 引用元論文 357 件、この内訳の 6.1%イタリア: 引用元論文 287 件、この内訳の 4.9%ドイツ: 引用元論文 248 件、この内訳の 4.3%カナダ: 引用元論文 242 件、この内訳の 4.2%フランス: 引用元論文 194 件、この内訳の 3.3%日本: 引用元論文 168 件、この内訳の 2.9%オーストラリア: 引用元論文 144 件、この内訳の 2.5%スペイン: 引用元論文 125 件、この内訳の 2.1%スイス: 引用元論文 109 件、この内訳の 1.9%オランダ: 引用元論文 109 件、この内訳の 1.9%
0%35.9%その他 23.1%

機関

分野

  • Medicine49.2%
  • Biochemistry, Genetics and Molecular Biology45.5%
  • Immunology and Microbiology1.8%
  • Computer Science0.7%
  • Materials Science0.6%
  • Engineering0.5%
  • その他1.7%

トピック

  • HER2/EGFR in Cancer Research6.4%
  • Breast Cancer Treatment Studies5.9%
  • Cancer-related Molecular Pathways3.7%
  • Monoclonal and Polyclonal Antibodies Research3.2%
  • Metabolism, Diabetes, and Cancer2.7%
  • Cancer Cells and Metastasis2.3%
  • その他75.8%

共著者

全論文

検索で開く
  1. Heterotrimerization of the Growth Factor Receptors erbB2, erbB3, and Insulin-like Growth Factor-I Receptor in Breast Cancer Cells Resistant to Herceptin

    著者: Xiaoping Huang, Li‐Zhi Gao, Shuiliang Wang, James L. McManaman, Ann D. Thor, Xiao-He Yang, Francisco J. Esteva, Bolin Liu - Cancer Research 2010 被引用: 246

  2. Role of the androgen receptor in breast cancer and preclinical analysis of enzalutamide

    著者: Dawn R. Cochrane, Sebastián Bernales, Britta M. Jacobsen, Diana M. Cittelly, Erin N. Howe, Nicholas C. D’Amato, Nicole S. Spoelstra, Susan M. Edgerton, Annie Jean, Javier Guerrero, Francisco Javier Gómez, Satyanarayana Medicherla, Iván E. Alfaro, Emma McCullagh, Paul Jedlicka, Kathleen C. Torkko, Ann D. Thor, Anthony Elias, Andrew A. Protter, Jennifer K. Richer - Breast Cancer Research 2014 被引用: 432

  3. ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization.

    著者: Olli Kallioniemi, Anne Kallioniemi, Wayne Kurisu, Ann D. Thor, L C Chen, Helene S. Smith, Fred Waldman, Daniel Pinkel, Joe W. Gray - National Academy of Sciences, Proceedings of the National Academy of Sciences 1992 被引用: 560

  4. Trastuzumab in the Treatment of Advanced Non-Small-Cell Lung Cancer: Is There a Role? Focus on Eastern Cooperative Oncology Group Study 2598

    著者: Corey J. Langer, Patricia Stephenson, Ann D. Thor, Márk Vangel, David H. Johnson - Journal of Clinical Oncology 2004 被引用: 225

  5. Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro

    著者: Irina Alimova, Bolin Liu, Zeying Fan, Susan M. Edgerton, Thomas E. Dillon, Stuart E. Lind, Ann D. Thor - Cell Cycle 2009 被引用: 525

  6. Downregulation of erbB3 abrogates erbB2‐mediated tamoxifen resistance in breast cancer cells

    著者: Bolin Liu, Dalia Ordonez‐Ercan, Zeying Fan, Susan M. Edgerton, Xiaohe Yang, Ann D. Thor - International Journal of Cancer 2007 被引用: 157

  7. Postpartum breast involution reveals regression of secretory lobules mediated by tissue-remodeling

    著者: Sonali Jindal, Dexiang Gao, Pat Bell, Grethe Albrektsen, Susan M. Edgerton, Christine B. Ambrosone, Ann D. Thor, Virginia F. Borges, Pepper Schedin - Breast Cancer Research 2014 被引用: 102

  8. Metformin targets Stat3 to inhibit cell growth and induce apoptosis in triple-negative breast cancers

    著者: Xin‐Sheng Deng, Shuiliang Wang, Anlong Deng, Bolin Liu, Susan M. Edgerton, Stuart E. Lind, Reema S. Wahdan-Alaswad, Ann D. Thor - Cell Cycle 2012 被引用: 210

  9. Metformin induces unique biological and molecular responses in triple negative breast cancer cells

    著者: Bolin Liu, Zeying Fan, Susan M. Edgerton, Xin‐Sheng Deng, Irina Alimova, Stuart E. Lind, Ann D. Thor - Cell Cycle 2009 被引用: 395

  10. Metformin-Induced Killing of Triple-Negative Breast Cancer Cells Is Mediated by Reduction in Fatty Acid Synthase via miRNA-193b

    著者: Reema S. Wahdan-Alaswad, Dawn R. Cochrane, Nicole S. Spoelstra, Erin N. Howe, Susan M. Edgerton, Steven M. Anderson, Ann D. Thor, Jennifer K. Richer - Hormones and Cancer 2014 被引用: 106

  11. Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem

    著者: Reema S. Wahdan-Alaswad, Bolin Liu, Ann D. Thor - Cancer Drug Resistance 2020 被引用: 36

  12. Glucose promotes breast cancer aggression and reduces metformin efficacy

    著者: Reema S. Wahdan-Alaswad, Zeying Fan, Susan M. Edgerton, Bolin Liu, Xin‐Sheng Deng, Sigrid S. Árnadóttir, Jennifer K. Richer, Steven M. Anderson, Ann D. Thor - Cell Cycle 2013 被引用: 126

  13. Revision of the American Joint Committee on Cancer Staging System for Breast Cancer

    著者: S. Eva Singletary, Craig Allred, Pandora Ashley, Lawrence W. Bassett, Donald A. Berry, Kirby I. Bland, Patrick I. Borgen, Gary M. Clark, Stephen B. Edge, Daniel F. Hayes, Lorie L. Hughes, R. V. P. Hutter, Monica Morrow, David L. Page, Abram Recht, Richard L. Theriault, Ann D. Thor, Donald L. Weaver, H. Samuel Wieand, Frederick L. Greene - Journal of Clinical Oncology 2002 被引用: 1,183

  14. Maspin, a Serpin with Tumor-Suppressing Activity in Human Mammary Epithelial Cells

    著者: Zhiqiang Zou, Anthony Anisowicz, Mary J.C. Hendrix, Ann D. Thor, Mark J. Neveu, Shijie Sheng, Kristina Rafidi, Elisabeth A. Seftor, Ruth Sager - Science 1994 被引用: 921

  15. Staging system for breast cancer: revisions for the 6th edition of the AJCC Cancer Staging Manual

    著者: S. Eva Singletary, Craig Allred, Pandora Ashley, Lawrence W. Bassett, Donald A. Berry, Kirby I. Bland, Patrick I. Borgen, Gary M. Clark, Stephen B. Edge, Daniel F. Hayes, Lorie L. Hughes, R. V. P. Hutter, Monica Morrow, David L. Page, Abram Recht, Richard L. Theriault, Ann D. Thor, Donald L. Weaver, H. Samuel Wieand, Frederick L. Greene - Surgical Clinics of North America 2003 被引用: 294

  16. Downregulation of miR-342 is associated with tamoxifen resistant breast tumors

    著者: Diana M. Cittelly, Partha Das, Nicole S. Spoelstra, Susan M. Edgerton, Jennifer K. Richer, Ann D. Thor, Frank E. Jones - Molecular Cancer 2010 被引用: 188

  17. The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression.

    著者: Chao Wang, Ann D. Thor, Dan H. Moore, Yong Zhao, Russell Kerschmann, Robert Stern, Peter H. Watson, Eva A. Turley - 1998 被引用: 180

  18. Potent anti-proliferative effects of metformin on trastuzumab-resistant breast cancer cells via inhibition of erbB2/IGF-1 receptor interactions

    著者: Bolin Liu, Zeying Fan, Susan M. Edgerton, Xiaohe Yang, Stuart E. Lind, Ann D. Thor - Cell Cycle 2011 被引用: 145

  19. Metformin Selectively Targets Tumor-Initiating Cells in ErbB2-Overexpressing Breast Cancer Models

    著者: Pei Zhu, Meghan B. Davis, Amanda J. Blackwelder, Nora Bachman, Bolin Liu, Susan M. Edgerton, Leonard Williams, Ann D. Thor, Xiaohe Yang - Cancer Prevention Research 2013 被引用: 85

  20. Upregulation of endogenous TRAIL-elicited apoptosis is essential for metformin-mediated antitumor activity against TNBC and NSCLC

    著者: Shuang Liu, Erik Polsdofer, Lukun Zhou, Sanbao Ruan, Hui Lyu, Defu Hou, Hao Liu, Ann D. Thor, Zhimin He, Bolin Liu - Molecular Therapy — Oncolytics 2021 被引用: 21

  21. Preventing ovariectomy-induced weight gain decreases tumor burden in rodent models of obesity and postmenopausal breast cancer

    著者: Elizabeth A. Wellberg, Karen A. Corleto, L. Allyson Checkley, Sonali Jindal, Ginger C. Johnson, Janine Higgins, Sarina Obeid, Steven M. Anderson, Ann D. Thor, Pepper J. Schedin, Paul S. MacLean, Erin D. Giles - Breast Cancer Research 2022 被引用: 19

  22. Cyclin D1 (PRAD1) protein expression in breast cancer: approximately one-third of infiltrating mammary carcinomas show overexpression of the cyclin D1 oncogene.

    著者: Lawrence Zukerberg, Woo Ick Yang, Michele A. Gadd, Ann D. Thor, F C Koerner, Emmett V. Schmidt, Andrew Arnold - 1995 被引用: 130

  23. Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas

    著者: Guoren Deng, You Lü, G Zlotnikov, Ann D. Thor, Helene S. Smith - Science 1996 被引用: 588

  24. Relationship of Epidermal Growth Factor Receptor Expression to ErbB-2 Signaling Activity and Prognosis in Breast Cancer Patients

    著者: Michael P. DiGiovanna, David F. Stern, Susan M. Edgerton, Steve G. Whalen, Dan H. Moore, Ann D. Thor - Journal of Clinical Oncology 2005 被引用: 233